(Total Views: 716)
Posted On: 02/13/2025 12:34:25 PM
Post# of 155795
From our Facebook page ….. Max Latalliade https://m.facebook.com/groups/622470341583807...tid=wwXIfr
Max Latalliade….This is why I joined the Gates Foundation!
On a recent trip with colleagues from the Gates Foundation and the University of Washington, we visited a remote village in Uganda to evaluate clinical trial sites for a novel long-acting agent. It was in this far-reaching gold mining community that I was warmly embraced by the most beautiful children. Yet, due to the local social, behavioral, and economic challenges, HIV transmission remains high.
After nearly 20 years as a physician scientist and researcher in Pharma-successfully developing several antivirals and antiretrovirals for HIV and HCV-I've had the privilege of advancing the science and strategy behind long-acting agents for HIV treatment and PrEP. Now, I've joined the Gates Foundation with a clear and ambitious goal: ending the HIV epidemic.
Yes, it's a big goal. But with current and near-term long-acting antiretrovirals-whether oral or injectables-we have a real opportunity to halt HIV transmission and make strides toward ending the epidemic.
These children deserve a future without the looming threat of HIV, a condition that is currently lifelong and often fatal in communities like theirs. Together, let's push the boundaries of what's possible and finish the job!
We have a great team behind us and they all have the best of intentions.
Max Latalliade….This is why I joined the Gates Foundation!
On a recent trip with colleagues from the Gates Foundation and the University of Washington, we visited a remote village in Uganda to evaluate clinical trial sites for a novel long-acting agent. It was in this far-reaching gold mining community that I was warmly embraced by the most beautiful children. Yet, due to the local social, behavioral, and economic challenges, HIV transmission remains high.
After nearly 20 years as a physician scientist and researcher in Pharma-successfully developing several antivirals and antiretrovirals for HIV and HCV-I've had the privilege of advancing the science and strategy behind long-acting agents for HIV treatment and PrEP. Now, I've joined the Gates Foundation with a clear and ambitious goal: ending the HIV epidemic.
Yes, it's a big goal. But with current and near-term long-acting antiretrovirals-whether oral or injectables-we have a real opportunity to halt HIV transmission and make strides toward ending the epidemic.
These children deserve a future without the looming threat of HIV, a condition that is currently lifelong and often fatal in communities like theirs. Together, let's push the boundaries of what's possible and finish the job!
We have a great team behind us and they all have the best of intentions.
(14)
(0)
